Literature DB >> 7891346

Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.

S E Shehin-Johnson1, D E Williams, S Larsen-Su, D M Stresser, R N Hines.   

Abstract

The microsomal flavin-containing monooxygenases (FMO) represent a family of xenobiotic-metabolizing enzymes with distinct tissue- and species-specific patterns of expression. Expression for two FMO isoforms (FMO1 and FMO2) in rabbit was characterized by determining mRNA levels, protein levels and catalytic activity in male and female liver, lung, kidney, esophagus, intestine, nasal mucosa (maxilloturbinates and ethmoturbinates) and gonadal tissue. Northern blot hybridization analyses performed with cDNA probes for each isoform showed marked differences in mRNA expression between tissues: FMO1 expression was highest in liver and intestine, followed by ethmoturbinates, maxilloturbinates and low but detectable levels in female kidney; FMO2 expression was highest in lung, followed by maxilloturbinates, ethmoturbinates, esophagus and kidney. More sex-related differences were observed for FMO2, with higher levels of mRNA in female esophagus, nasal mucosa and kidney. Western blot analyses showed similar patterns of expression at the protein level. Microsomal catalytic activities determined by [14C]-DMA N-oxide formation also indicated tissue- and sex-related differences in substrate metabolism by FMO. Analysis of tissue-specific FMO catalytic activity was also performed using thiocarbamides as isoform-specific probes. Microsomes from those tissues containing FMO2, but not FMO1, failed to catalyze oxidation of the larger (van der Waals surface area greater than 178 A) FMO1-specific thiocarbamides. The results of this study demonstrate that tissue-specific control mechanisms play a more dominant role in the overall constitutive regulation of FMO than other potential factors, such as hormonal influences. Elucidation of the mechanisms controlling FMO tissue-specific expression will lead to a better understanding of target organ specificity for xenobiotic detoxication or bioactivation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7891346

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

Review 1.  Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism.

Authors:  Sharon K Krueger; David E Williams
Journal:  Pharmacol Ther       Date:  2005-06       Impact factor: 12.310

2.  Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.

Authors:  Sharon K Krueger; Lisbeth K Siddens; Marilyn C Henderson; Eric A Andreasen; Robert L Tanguay; Clifford B Pereira; Erwin T Cabacungan; Ronald N Hines; Kristin G Ardlie; David E Williams
Journal:  Pharmacogenet Genomics       Date:  2005-04       Impact factor: 2.089

Review 3.  Flavin Containing Monooxygenases and Metabolism of Xenobiotics.

Authors:  Rahman Başaran; Benay Can Eke
Journal:  Turk J Pharm Sci       Date:  2017-04-15

4.  The tissue-specific toxicity of methimazole in the mouse olfactory mucosa is partly mediated through target-tissue metabolic activation by CYP2A5.

Authors:  Fang Xie; Xin Zhou; Mary Beth Genter; Melissa Behr; Jun Gu; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2011-03-17       Impact factor: 3.922

5.  Constraints on the evolution of a doublesex target gene arising from doublesex's pleiotropic deployment.

Authors:  Shengzhan D Luo; Bruce S Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

6.  Characterization of sulfoxygenation and structural implications of human flavin-containing monooxygenase isoform 2 (FMO2.1) variants S195L and N413K.

Authors:  Sharon K Krueger; Marilyn C Henderson; Lisbeth K Siddens; Jonathan E VanDyke; Abby D Benninghoff; P Andrew Karplus; Bjarte Furnes; Daniel Schlenk; David E Williams
Journal:  Drug Metab Dispos       Date:  2009-05-06       Impact factor: 3.922

7.  Flavin-containing monooxygenase S-oxygenation of a series of thioureas and thiones.

Authors:  Marilyn C Henderson; Lisbeth K Siddens; Sharon K Krueger; J Fred Stevens; Karen Kedzie; Wenkui K Fang; Todd Heidelbaugh; Phong Nguyen; Ken Chow; Michael Garst; Daniel Gil; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2014-04-12       Impact factor: 4.219

8.  Metabolism of the anti-tuberculosis drug ethionamide by mouse and human FMO1, FMO2 and FMO3 and mouse and human lung microsomes.

Authors:  Marilyn C Henderson; Lisbeth K Siddens; Jeffrey T Morré; Sharon K Krueger; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2008-10-01       Impact factor: 4.219

9.  Alternative promoters and repetitive DNA elements define the species-dependent tissue-specific expression of the FMO1 genes of human and mouse.

Authors:  Elizabeth A Shephard; Pritpal Chandan; Milena Stevanovic-Walker; Mina Edwards; Ian R Phillips
Journal:  Biochem J       Date:  2007-09-15       Impact factor: 3.857

Review 10.  Properties and Mechanisms of Flavin-Dependent Monooxygenases and Their Applications in Natural Product Synthesis.

Authors:  Yaming Deng; Quan Zhou; Yuzhou Wu; Xi Chen; Fangrui Zhong
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.